Sfoglia per Autore
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter
2019-01-01 Bianconi, M.; Cimadamore, A.; Faloppi, L.; Scartozzi, M.; Santoni, M.; Lopez-Beltran, A.; Cheng, L.; Scarpelli, M.; Montironi, R.
Prostate Cancer Grading: Are We Heading Towards Grade Grouping Version 2?
2019-01-01 Montironi, R.; Cheng, L.; Cimadamore, A.; Lopez-Beltran, A.
Immunotherapy in renal cell carcinoma from poverty to the spoiled of choice
2019-01-01 Massari, F.; Nunno, V. D.; Mollica, V.; Montironi, R.; Cheng, L.; Cimadamore, A.; Blanca, A.; Lopez-Beltran, A.
Editorial: Emerging biomarkers in genitourinary tumors
2019-01-01 Montironi, R.; Santoni, M.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.
Inguinal bladder hernia with lipomatosis of the bladder wall: A potential clinical pitfall for cancer
2019-01-01 Cimadamore, Alessia; Palagonia, Erika; Piccinni, Paola; Misericordia, Marco; Galosi, Andrea Benedetto; Montironi, Rodolfo
Prostate cancer pathology: What has changed in the last 5 years
2019-01-01 Cimadamore, Alessia; Scarpelli, Marina; Raspollini, Maria Rosaria; Doria, Andrea; Galosi, Andrea Benedetto; Massari, Francesco; Di Nunno, Vincenzo; Cheng, Liang; Lopez-Beltran, Antonio; Montironi, Rodolfo
Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samples
2019-01-01 Volavsek, M.; Henriques, V.; Blanca, A.; Montironi, R.; Cheng, L.; Raspollini, M. R.; Cimadamore, A.; Vau, N.; Pierconti, F.; Lopez-Beltran, A.
Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma
2019-01-01 Santoni, Matteo; Heng, Daniel Yc; Aurilio, Gaetano; Iozzelli, Andrea; Servi, Lucilla; Fabiani, Andrea; Giannini, Massimo; Mazzucchelli, Roberta; Cimadamore, Alessia; Scarpelli, Marina; Zaghloul, Mohamed S; Battelli, Nicola; Montironi, Rodolfo
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution
2019-01-01 Mollica, V.; Di Nunno, V.; Gatto, L.; Santoni, M.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Pisconti, S.; Battelli, N.; Massari, F.
Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: Where we stand and where we go
2019-01-01 Gevaert, T.; Cimadamore, A.; Eckstein, M.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Montironi, R.
Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype
2019-01-01 Rebola, J.; Aguiar, P.; Blanca, A.; Montironi, R.; Cimadamore, A.; Cheng, L.; Henriques, V.; Lobato-Faria, P.; Lopez-Beltran, A.
Biphasic Tumors of the Urogenital Tract: Selected Topics
2019-01-01 Montironi, R; Mazzucchelli, R; Gasparrini, S; Cimadamore, A; Galosi, Ab; Raspollini, Mr; Lopez-Beltran, A; Cheng, L; Scarpelli, M
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians
2019-01-01 Gasparrini, S.; Cimadamore, A.; Scarpelli, M.; Massari, F.; Doria, A.; Mazzucchelli, R.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
Extramammary Paget disease of the penis closely mimicking the penile analogue of stratified mucin-producing intraepithelial lesion
2019-01-01 Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
OUTCOMES OF DIFFERENT PATTERN OF SEMINAL VESICLE INVASION IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY
2019-01-01 Montesi, L; Palagonia, E; Leone, L; Capretti, C; Cimadamore, A; Dell'Atti, L; Galosi, Ab; Montironi, R
Variants and new entities of bladder cancer
2019-01-01 Lopez-Beltran, A.; Henriques, V.; Montironi, R.; Cimadamore, A.; Raspollini, M. R.; Cheng, L.
Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer
2019-01-01 Blanca, A.; Sanchez-Gonzalez, A.; Requena, M. J.; Carrasco-Valiente, J.; Gomez-Gomez, E.; Cheng, L.; Cimadamore, A.; Montironi, R.; Lopez-Beltran, A.
The Prostatic Utricle and Endometrioid Prostate Cancer: Similarities, Differences and Challenges
2019-01-01 Montironi, R; Mazzucchelli, R; Gasparrini, S; Cimadamore, A; Galosi, Ab; Raspollini, Mr; Lopez-Beltran, A; Cheng, L; Scarpelli, M
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies
2019-01-01 Santoni, M.; Conti, A.; Massari, F.; Di Nunno, V.; Faloppi, L.; Galizia, E.; Morbiducci, J.; Piva, F.; Buti, S.; Iacovelli, R.; Ferretti, B.; Cimadamore, A.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Montironi, R.
The role of obesity in renal cell carcinoma patients: Clinical-pathological implications
2019-01-01 Aurilio, G.; Piva, F.; Santoni, M.; Cimadamore, A.; Sorgentoni, G.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Nole, F.; Montironi, R.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter | 1-gen-2019 | Bianconi, M.; Cimadamore, A.; Faloppi, L.; Scartozzi, M.; Santoni, M.; Lopez-Beltran, A.; Cheng, L.; Scarpelli, M.; Montironi, R. | |
Prostate Cancer Grading: Are We Heading Towards Grade Grouping Version 2? | 1-gen-2019 | Montironi, R.; Cheng, L.; Cimadamore, A.; Lopez-Beltran, A. | |
Immunotherapy in renal cell carcinoma from poverty to the spoiled of choice | 1-gen-2019 | Massari, F.; Nunno, V. D.; Mollica, V.; Montironi, R.; Cheng, L.; Cimadamore, A.; Blanca, A.; Lopez-Beltran, A. | |
Editorial: Emerging biomarkers in genitourinary tumors | 1-gen-2019 | Montironi, R.; Santoni, M.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L. | |
Inguinal bladder hernia with lipomatosis of the bladder wall: A potential clinical pitfall for cancer | 1-gen-2019 | Cimadamore, Alessia; Palagonia, Erika; Piccinni, Paola; Misericordia, Marco; Galosi, Andrea Benedetto; Montironi, Rodolfo | |
Prostate cancer pathology: What has changed in the last 5 years | 1-gen-2019 | Cimadamore, Alessia; Scarpelli, Marina; Raspollini, Maria Rosaria; Doria, Andrea; Galosi, Andrea Benedetto; Massari, Francesco; Di Nunno, Vincenzo; Cheng, Liang; Lopez-Beltran, Antonio; Montironi, Rodolfo | |
Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samples | 1-gen-2019 | Volavsek, M.; Henriques, V.; Blanca, A.; Montironi, R.; Cheng, L.; Raspollini, M. R.; Cimadamore, A.; Vau, N.; Pierconti, F.; Lopez-Beltran, A. | |
Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma | 1-gen-2019 | Santoni, Matteo; Heng, Daniel Yc; Aurilio, Gaetano; Iozzelli, Andrea; Servi, Lucilla; Fabiani, Andrea; Giannini, Massimo; Mazzucchelli, Roberta; Cimadamore, Alessia; Scarpelli, Marina; Zaghloul, Mohamed S; Battelli, Nicola; Montironi, Rodolfo | |
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution | 1-gen-2019 | Mollica, V.; Di Nunno, V.; Gatto, L.; Santoni, M.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Pisconti, S.; Battelli, N.; Massari, F. | |
Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: Where we stand and where we go | 1-gen-2019 | Gevaert, T.; Cimadamore, A.; Eckstein, M.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Montironi, R. | |
Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype | 1-gen-2019 | Rebola, J.; Aguiar, P.; Blanca, A.; Montironi, R.; Cimadamore, A.; Cheng, L.; Henriques, V.; Lobato-Faria, P.; Lopez-Beltran, A. | |
Biphasic Tumors of the Urogenital Tract: Selected Topics | 1-gen-2019 | Montironi, R; Mazzucchelli, R; Gasparrini, S; Cimadamore, A; Galosi, Ab; Raspollini, Mr; Lopez-Beltran, A; Cheng, L; Scarpelli, M | |
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians | 1-gen-2019 | Gasparrini, S.; Cimadamore, A.; Scarpelli, M.; Massari, F.; Doria, A.; Mazzucchelli, R.; Cheng, L.; Lopez-Beltran, A.; Montironi, R. | |
Extramammary Paget disease of the penis closely mimicking the penile analogue of stratified mucin-producing intraepithelial lesion | 1-gen-2019 | Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Montironi, R. | |
OUTCOMES OF DIFFERENT PATTERN OF SEMINAL VESICLE INVASION IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY | 1-gen-2019 | Montesi, L; Palagonia, E; Leone, L; Capretti, C; Cimadamore, A; Dell'Atti, L; Galosi, Ab; Montironi, R | |
Variants and new entities of bladder cancer | 1-gen-2019 | Lopez-Beltran, A.; Henriques, V.; Montironi, R.; Cimadamore, A.; Raspollini, M. R.; Cheng, L. | |
Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer | 1-gen-2019 | Blanca, A.; Sanchez-Gonzalez, A.; Requena, M. J.; Carrasco-Valiente, J.; Gomez-Gomez, E.; Cheng, L.; Cimadamore, A.; Montironi, R.; Lopez-Beltran, A. | |
The Prostatic Utricle and Endometrioid Prostate Cancer: Similarities, Differences and Challenges | 1-gen-2019 | Montironi, R; Mazzucchelli, R; Gasparrini, S; Cimadamore, A; Galosi, Ab; Raspollini, Mr; Lopez-Beltran, A; Cheng, L; Scarpelli, M | |
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies | 1-gen-2019 | Santoni, M.; Conti, A.; Massari, F.; Di Nunno, V.; Faloppi, L.; Galizia, E.; Morbiducci, J.; Piva, F.; Buti, S.; Iacovelli, R.; Ferretti, B.; Cimadamore, A.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Montironi, R. | |
The role of obesity in renal cell carcinoma patients: Clinical-pathological implications | 1-gen-2019 | Aurilio, G.; Piva, F.; Santoni, M.; Cimadamore, A.; Sorgentoni, G.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Nole, F.; Montironi, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile